Literature DB >> 22609121

Hemoglobin drift after cardiac surgery.

Timothy J George1, Claude A Beaty, Arman Kilic, Kara A Haggerty, Steven M Frank, William J Savage, Glenn J Whitman.   

Abstract

BACKGROUND: Recent literature suggests that a restrictive approach to red blood cell transfusions is associated with improved outcomes in cardiac surgery patients. Even in the absence of bleeding, intravascular fluid shifts cause hemoglobin levels to drift postoperatively, possibly confounding the decision to transfuse. The purpose of this study was to define the natural progression of hemoglobin levels in postoperative cardiac surgery patients.
METHODS: All cardiac surgery patients from October 2010 through March 2011 who did not receive a postoperative transfusion were included. Primary stratification was by intraoperative transfusion status. Change in hemoglobin was evaluated relative to the initial postoperative hemoglobin. Maximal drift was defined as the maximum minus the minimum hemoglobin for a given hospitalization. Final drift was defined as the difference between initial and discharge hemoglobin.
RESULTS: The final cohort included 199 patients: 71 (36%) received an intraoperative transfusion, whereas 128 (64%) did not. The average initial and final hemoglobin levels for all patients were 11.0±1.4 g/dL and 9.9±1.3 g/dL, respectively, giving a final drift of 1.1±1.4 g/dL. The maximal drift was 1.8±1.1 g/dL and was similar regardless of intraoperative transfusion status (p=0.9). Although all patients' hemoglobin initially dropped, 79% of patients reached a nadir and experienced a mean recovery of 0.7±0.7 g/dL by discharge. On multivariable analysis, increasing cardiopulmonary bypass time was significantly associated with total hemoglobin drift (coefficient/hour, 0.3 [0.1-0.5] g/dL; p=0.02).
CONCLUSIONS: In this report of hemoglobin drift after cardiac surgery, although all postoperative patients experienced downward hemoglobin drift, 79% of patients exhibited hemoglobin recovery before discharge. Physicians should consider the eventual upward hemoglobin drift before administering red blood cell transfusions.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22609121      PMCID: PMC3610599          DOI: 10.1016/j.athoracsur.2012.03.038

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  17 in total

1.  Transfusion in coronary artery bypass grafting is associated with reduced long-term survival.

Authors:  Colleen Gorman Koch; Liang Li; Andra I Duncan; Tomislav Mihaljevic; Floyd D Loop; Norman J Starr; Eugene H Blackstone
Journal:  Ann Thorac Surg       Date:  2006-05       Impact factor: 4.330

2.  Capillary leakage in cardiac surgery with cardiopulmonary bypass.

Authors:  Yoshihiro Hamada; Kanji Kawachi; Nobuo Tsunooka; Yoshitsugu Nakamura; Shinji Takano; Hiroshi Imagawa
Journal:  Asian Cardiovasc Thorac Ann       Date:  2004-09

3.  Changes in circulating blood volume after cardiac surgery measured by a novel method using hydroxyethyl starch.

Authors:  K Tschaikowsky; U Neddermeyer; E Pscheidl; J von der Emde
Journal:  Crit Care Med       Date:  2000-02       Impact factor: 7.598

4.  Systemic inflammatory response syndrome after cardiac operations.

Authors:  J Cremer; M Martin; H Redl; S Bahrami; C Abraham; T Graeter; A Haverich; G Schlag; H G Borst
Journal:  Ann Thorac Surg       Date:  1996-06       Impact factor: 4.330

5.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.

Authors:  P C Hébert; G Wells; M A Blajchman; J Marshall; C Martin; G Pagliarello; M Tweeddale; I Schweitzer; E Yetisir
Journal:  N Engl J Med       Date:  1999-02-11       Impact factor: 91.245

6.  Effect of blood transfusion on long-term survival after cardiac operation.

Authors:  Milo C Engoren; Robert H Habib; Anoar Zacharias; Thomas A Schwann; Christopher J Riordan; Samuel J Durham
Journal:  Ann Thorac Surg       Date:  2002-10       Impact factor: 4.330

7.  Microvascular permeability after cardiopulmonary bypass. An experimental study.

Authors:  E E Smith; D C Naftel; E H Blackstone; J W Kirklin
Journal:  J Thorac Cardiovasc Surg       Date:  1987-08       Impact factor: 5.209

8.  Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery.

Authors:  Manoj Kuduvalli; Aung Y Oo; Nick Newall; Antony D Grayson; Mark Jackson; Michael J Desmond; Brian M Fabri; Abbas Rashid
Journal:  Eur J Cardiothorac Surg       Date:  2005-04       Impact factor: 4.191

9.  Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting.

Authors:  Colleen Gorman Koch; Liang Li; Andra I Duncan; Tomislav Mihaljevic; Delos M Cosgrove; Floyd D Loop; Norman J Starr; Eugene H Blackstone
Journal:  Crit Care Med       Date:  2006-06       Impact factor: 7.598

10.  Inflammatory reaction and capillary leak syndrome related to cardiopulmonary bypass in neonates undergoing cardiac operations.

Authors:  M C Seghaye; R G Grabitz; J Duchateau; S Busse; S Däbritz; D Koch; G Alzen; H Hörnchen; B J Messmer; G Von Bernuth
Journal:  J Thorac Cardiovasc Surg       Date:  1996-09       Impact factor: 5.209

View more
  5 in total

1.  The Influence of Intraoperative Autotransfusion on Postoperative Hematocrit after Cardiac Surgery: A Cross-Sectional Study.

Authors:  Andrew J Stasko; Alfred H Stammers; Linda B Mongero; Eric A Tesdahl; Samuel Weinstein
Journal:  J Extra Corpor Technol       Date:  2017-12

2.  Perioperative blood loss: estimation of blood volume loss or haemoglobin mass loss?

Authors:  Sebastian Jaramillo; Mar Montane-Muntane; Pedro L Gambus; David Capitan; Ricard Navarro-Ripoll; Annabel Blasi
Journal:  Blood Transfus       Date:  2019-11-27       Impact factor: 3.443

3.  Evaluation of VEP parameters in patients before and after cardiopulmonary by-pass surgery.

Authors:  Alper Güneş; Şerife Gülhan Konuk; Helin Deniz Demir; Semiha Kurt; Erdinç Naseri; Ünal Erkorkmaz
Journal:  Int Ophthalmol       Date:  2022-07-21       Impact factor: 2.029

4.  Intravenous iron isomaltoside 1000 (Monofer®) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial).

Authors:  P I Johansson; A S Rasmussen; L L Thomsen
Journal:  Vox Sang       Date:  2015-04-20       Impact factor: 2.144

5.  Perioperative changes in hemoglobin levels during major hepatopancreatic surgery in transfused and non-transfused patients.

Authors:  J P Lammi; Matti Eskelinen; Jarno Tuimala; Tuomas Selander; Juha Saarnio; Tuomo Rantanen
Journal:  Scand J Surg       Date:  2020-10-29       Impact factor: 2.360

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.